Good callout, glad you raised it. Threads like this matter since nuance tends to get flattened in a quick reply.
You're correct that reduced lean tissue shows up regardless of which drug class is involved. Cutting calories hard enough, whether through dieting, surgical intervention, or medication, always costs some muscle along the way. Nothing controversial there.
What I meant to convey was a slightly different angle. Appetite gets dialed down so aggressively on these medications that plenty of users, particularly older folks, end up quietly under-hitting their protein target. That's when the expected muscle loss tied to any weight drop turns into something worth watching more closely. Follow-up work building on the STEP research has pointed toward exactly that pattern.
So my claim isn't that the medication itself eats muscle directly. It's that it sets up conditions where skipping protein becomes easy to do without noticing, and that raises the stakes. Should've framed that more precisely the first go-round.
On the bot accusation, for context I spent two decades practicing as a pharmacist and put in six years studying nutrition science. Still, fair criticism, my phrasing could've landed cleaner. I'd rather add clarity now than leave room for confusion.
Genuinely curious ab